Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.03 - Poster Session 1 - Technology and Novel Development

    • Type: Poster Session
    • Track: Biology
    • Presentations: 6
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.03-001 - Multiplexing technology for in situ biomarker profiling of Non-Small Cell Lung Cancer (NSCLC)

      09:30 - 09:30  |  Author(s): A. Sood

      • Abstract

      Loading...

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-012 - A disintegrin and metalloproteinase-9 is highly expressed, correlated with lymph nodes metastasis, predicts worse prognosis and may help improving personalized postoperative treatment in resected non-small cell lung cancer

      09:30 - 09:30  |  Author(s): J. Zhang

      • Abstract

      Loading...

  • +

    P1.07 - Poster Session 1 - Surgery

    • Type: Poster Session
    • Track: Surgery
    • Presentations: 48
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.07-013 - "Minimally invasive small incision, muscle- and rib-sparing thoracotomy, minimally invasive lung cancer radical surgery", cures "aging, cardiopulmonary dysfunction patients with lung cancer"

      09:30 - 09:30  |  Author(s): J. Zhang

      • Abstract

      Loading...

  • +

    P1.08 - Poster Session 1 - Radiotherapy

    • Type: Poster Session
    • Track: Radiation Oncology + Radiotherapy
    • Presentations: 27
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.08-001 - Correlation of intra-fraction displacement of the mediastinal metastatic lymph nodes with primary tumor, lung and heart based on 4DCT in non-small cell lung cancer

      09:30 - 09:30  |  Author(s): S.Z. Wang

      • Abstract

      Loading...

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-036 - The efficacy and safety of sunitinib in EGFR-TKI pretreated advanced non-small cell lung cancer: a retrospective review from Chinese patients at a single institution

      09:30 - 09:30  |  Author(s): L. Jiang

      • Abstract

      Loading...

  • +

    MO07 - NSCLC - Targeted Therapies II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:T. John
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
    • +

      MO07.06 - Updated results of a first-in-human dose-finding study of the ALK/EGFR inhibitor AP26113 in patients with advanced malignancies

      16:45 - 16:50  |  Author(s): D..R. Camidge

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO10 - Molecular Pathology II

    • Type: Mini Oral Abstract Session
    • Track: Pathology
    • Presentations: 13
    • Moderators:W.A. Franklin
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 104, Level 1
    • +

      MO10.07 - ALK immunohistochemistry and fluorescence in-situ hybridization in Lung adenocarcinomas from the ETOP Lungscape tumour cohort

      16:50 - 16:55  |  Author(s): K.M. Kerr

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O10 - Stereotactic Ablative Body Radiotherapy

    • Type: Oral Abstract Session
    • Track: Radiation Oncology + Radiotherapy
    • Presentations: 8
    • Moderators:H. Onishi
    • Coordinates: 10/28/2013, 16:15 - 17:45, Parkside 110 A+B, Level 1
    • +

      O10.01 - Exploring the optimal biologically effective dose of stereotactic body radiation therapy for Stage I non-small-cell lung cancer - An update

      16:15 - 16:25  |  Author(s): J. Wang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.02 - Poster Session 2 - Novel Cancer Genes and Pathways

    • Type: Poster Session
    • Track: Biology
    • Presentations: 21
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.02-007 - HDGF, ADAM9 involved in a novel pathway of cell growth and invasion of non-small cell lung cancer cells, may become novel molecular staging biomarkers, prognostic and predictive biomarkers of NSCLC

      11:12 - 11:29  |  Author(s): J. Zhang

      • Abstract

      Loading...

  • +

    P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging

    • Type: Poster Session
    • Track: Biology
    • Presentations: 27
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.05-022 - Therapeutic potential of the FGFR Tyrosine Kinase Inhibitor, AZD4547 in Squamous non-small cell lung cancer

      09:30 - 09:30  |  Author(s): P. Gavine

      • Abstract

      Loading...